Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
USA118th CongressS-1852| Senate
| Updated: 9/6/2023
Tim Scott
Republican Senator
South Carolina
Health, Education, Labor, and Pensions Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Bill from Previous Congress
S 115-2465Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.
Latest Companion Bill Action
HR 118-3884Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health
Blood and blood diseasesGeneticsHealth promotion and preventive careHereditary and development disordersMedical researchResearch administration and funding
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
USA118th CongressS-1852| Senate
| Updated: 9/6/2023
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Bill from Previous Congress
S 115-2465Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.
Latest Companion Bill Action
HR 118-3884Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Tim Scott
Republican Senator
South Carolina
Health, Education, Labor, and Pensions Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Blood and blood diseasesGeneticsHealth promotion and preventive careHereditary and development disordersMedical researchResearch administration and funding